Open-Label, Randomized, Multicenter, Parallel-Group Efficacy and Safety Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2012
At a glance
- Drugs Tacrolimus (Primary) ; Methylprednisolone; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 18 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Aug 2008 New trial record.